Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR

Antonio Jiménez(University of Miami), Brian C. Shaffer(Memorial Sloan Kettering Cancer Center), Marcelo Fernández-Viña(The University of Texas Southwestern Medical Center), Mitchell E. Horwitz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Medhat Askar(Baylor University Medical Center), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Muna Qayed(Emory University), Martin Maiers(National Marrow Donor Program), Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), Jason Dehn(National Marrow Donor Program), Mahasweta Gooptu(Harvard University), Monzr M. Al Malki(City of Hope), Yung‐Tsi Bolon(National Marrow Donor Program), Heather E. Stefanski(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Shannon R. McCurdy(Hospital of the University of Pennsylvania), Jeffery J. Auletta(Nationwide Children's Hospital), Jennifer Wilder(Science Applications International Corporation (United States)), Larisa Broglie(Morgan Stanley Children's Hospital), Joseph A. Pidala(Moffitt Cancer Center), Ioannis Politikos(Beth Israel Deaconess Medical Center), Craig Malmberg(National Marrow Donor Program), Steven M. Devine(National Marrow Donor Program)
Transplantation and Cellular Therapy
July 5, 2025
Cited by 33


Related Papers